Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.9B | 6.4B | 6.0B | 6.0B |
Cost of revenue | 1.9B | 2.3B | 1.7B | 1.8B |
Gross profit | 4.0B | 4.1B | 4.2B | 4.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1B | 1.0B | 1.0B | 1.0B |
Other operating expenses | 482M | 502M | 480M | 460M |
Operating income | 1.3B | 1.4B | 1.5B | 1.4B |
Non operating interest income | ||||
Income | 51M | -43M | 60M | 50M |
Expense | 423M | 406M | 449M | 434M |
Other income expense | 26M | -292M | -2.3B | -208M |
Pretax income | 940M | 680M | -1.2B | 835M |
Tax provision | 257M | 175M | 5M | 231M |
Net income | 683M | 505M | -1.2B | 604M |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 2.6B | 2.7B | 2.6B | 2.7B |
Net income from continuing op. | 683M | 505M | -1.2B | 604M |
Minority interests | -12M | -1M | -1M | -21M |
Preferred stock dividends | — | — | — | — |